Sangon Biotech Completes $10M Round of Funding from Qiming Ventures

Sangon Biotech, a Shanghai-based life science research service company and subsidiary of of Toronto, CA-based Bio Basic Inc., completed a $10m round of funding from Qiming Ventures.
The company is using the funding to scale research & development, marketing and sales of its life science research tools including biochemical reagents, protein, antibody, research kit, DNA synthesis service, etc. to meet increasing demand.
In conjunction with the funding, Nisa Lin and William Hu from Qiming Venture Partners joined the company’s board.
BBI, thorugh its sales network operating in 40 countries, provides life science research tools and services including Molecular Biology Kits, Biochemicals, Synthetic Genes and Synthetic Oligos.

Join the discussion